Zwaan, Christian M <br/><br/>
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis.  [electronic resource] 

 -  Blood  May 2003 
 - 3868-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2002-07-1947  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Aminoglycosides<br/>Anti-Bacterial Agents--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bone Marrow Cells--pathology<br/>Child<br/>Child, Preschool<br/>Gemtuzumab<br/>Humans<br/>Immunotoxins--therapeutic use<br/>Infant<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Recurrence<br/>Treatment Outcome